Literature DB >> 10160475

The impact of user charges on the consumption of drugs. Empirical evidence and economic implications.

U G Gerdtham1, M Johannesson.   

Abstract

Expenditure on drugs is increasing rapidly in many countries, and this has led to increased interest in measures to contain drug expenditure. One measure that has been discussed is to increase user charges for prescription drug. In this article, we consider whether or not raising user charges decreases the consumption of drugs. We also discuss how to judge if increased user charges for drugs are desirable from an economic viewpoint. We conclude that the decision to increase user charges for prescription drugs should not be viewed as an issue of cost containment, but as a matter of balancing the societal costs against the societal benefits of increased user charges.

Mesh:

Year:  1996        PMID: 10160475     DOI: 10.2165/00019053-199609060-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  14 in total

1.  The effect of patient charges on the utilisation of prescription medicines.

Authors:  B O'Brien
Journal:  J Health Econ       Date:  1989-03       Impact factor: 3.883

2.  The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization.

Authors:  B L Harris; A Stergachis; L D Ried
Journal:  Med Care       Date:  1990-10       Impact factor: 2.983

Review 3.  Willingness to pay for antihypertensive therapy--further results.

Authors:  M Johannesson; P O Johansson; B Kriström; U G Gerdtham
Journal:  J Health Econ       Date:  1993-04       Impact factor: 3.883

4.  Termination of Medi-Cal benefits. A follow-up study one year later.

Authors:  N Lurie; N B Ward; M F Shapiro; C Gallego; R Vaghaiwalla; R H Brook
Journal:  N Engl J Med       Date:  1986-05-08       Impact factor: 91.245

5.  The demand for prescription drugs as a function of cost-sharing.

Authors:  A Leibowitz; W G Manning; J P Newhouse
Journal:  Soc Sci Med       Date:  1985       Impact factor: 4.634

6.  Termination from Medi-Cal--does it affect health?

Authors:  N Lurie; N B Ward; M F Shapiro; R H Brook
Journal:  N Engl J Med       Date:  1984-08-16       Impact factor: 91.245

7.  Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

Authors:  S B Soumerai; J Avorn; D Ross-Degnan; S Gortmaker
Journal:  N Engl J Med       Date:  1987-08-27       Impact factor: 91.245

8.  Some interim results from a controlled trial of cost sharing in health insurance.

Authors:  J P Newhouse; W G Manning; C N Morris; L L Orr; N Duan; E B Keeler; A Leibowitz; K H Marquis; M S Marquis; C E Phelps; R H Brook
Journal:  N Engl J Med       Date:  1981-12-17       Impact factor: 91.245

9.  Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes.

Authors:  S B Soumerai; D Ross-Degnan; J Avorn; T j McLaughlin; I Choodnovskiy
Journal:  N Engl J Med       Date:  1991-10-10       Impact factor: 91.245

10.  Health insurance and the demand for medical care: evidence from a randomized experiment.

Authors:  W G Manning; J P Newhouse; N Duan; E B Keeler; A Leibowitz; M S Marquis
Journal:  Am Econ Rev       Date:  1987-06
View more
  2 in total

1.  Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?

Authors:  Michael Drummond; Adrian Towse
Journal:  Eur J Health Econ       Date:  2012-02

2.  What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Authors:  Marin C Gemmill; Sarah Thomson; Elias Mossialos
Journal:  Int J Equity Health       Date:  2008-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.